LUXURBAN HOTELS INC (LUXH)

US21985R1059 - Common Stock

1.085  -0.11 (-9.58%)

Premarket: 1.13 +0.04 (+4.15%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to LUXH. LUXH was compared to 65 industry peers in the Real Estate Management & Development industry. LUXH may be in some trouble as it scores bad on both profitability and health. LUXH is not valued too expensively and it also shows a decent growth rate.



0

1. Profitability

1.1 Basic Checks

In the past year LUXH was profitable.
LUXH had a negative operating cash flow in the past year.
LUXH had negative earnings in each of the past 5 years.
LUXH had negative operating cash flow in 4 of the past 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of -74.66%, LUXH is doing worse than 90.63% of the companies in the same industry.
Industry RankSector Rank
ROA -74.66%
ROE N/A
ROIC N/A
ROA(3y)-31.72%
ROA(5y)-235.83%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

LUXH does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

1

2. Health

2.1 Basic Checks

LUXH does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for LUXH has been reduced compared to 1 year ago.
LUXH has a better debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of -2.97, we must say that LUXH is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of LUXH (-2.97) is worse than 85.94% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -2.97
ROIC/WACCN/A
WACC10.91%

2.3 Liquidity

A Current Ratio of 0.03 indicates that LUXH may have some problems paying its short term obligations.
LUXH's Current ratio of 0.03 is on the low side compared to the rest of the industry. LUXH is outperformed by 96.88% of its industry peers.
LUXH has a Quick Ratio of 0.03. This is a bad value and indicates that LUXH is not financially healthy enough and could expect problems in meeting its short term obligations.
LUXH has a worse Quick ratio (0.03) than 96.88% of its industry peers.
Industry RankSector Rank
Current Ratio 0.03
Quick Ratio 0.03

6

3. Growth

3.1 Past

The earnings per share for LUXH have decreased strongly by -16327.37% in the last year.
Looking at the last year, LUXH shows a very negative growth in Revenue. The Revenue has decreased by -19.87% in the last year.
LUXH shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 103.08% yearly.
EPS 1Y (TTM)-16327.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-15123.51%
Revenue 1Y (TTM)-19.87%
Revenue growth 3Y103.08%
Revenue growth 5YN/A
Sales Q2Q%-57.92%

3.2 Future

LUXH is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 31.90% yearly.
Based on estimates for the next years, LUXH will show a very strong growth in Revenue. The Revenue will grow by 44.67% on average per year.
EPS Next Y-217.94%
EPS Next 2Y-20.16%
EPS Next 3Y31.9%
EPS Next 5YN/A
Revenue Next Year-5.75%
Revenue Next 2Y4.34%
Revenue Next 3Y46.34%
Revenue Next 5Y44.67%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

6

4. Valuation

4.1 Price/Earnings Ratio

LUXH is valuated cheaply with a Price/Earnings ratio of 3.39.
96.88% of the companies in the same industry are more expensive than LUXH, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of LUXH to the average of the S&P500 Index (29.70), we can say LUXH is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 5.32, the valuation of LUXH can be described as very cheap.
Based on the Price/Forward Earnings ratio, LUXH is valued cheaper than 100.00% of the companies in the same industry.
LUXH's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 24.16.
Industry RankSector Rank
PE 3.39
Fwd PE 5.32

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as LUXH's earnings are expected to grow with 31.90% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-20.16%
EPS Next 3Y31.9%

0

5. Dividend

5.1 Amount

LUXH does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

LUXURBAN HOTELS INC

NASDAQ:LUXH (12/2/2024, 8:00:00 PM)

Premarket: 1.13 +0.04 (+4.15%)

1.085

-0.11 (-9.58%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap164.76M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 3.39
Fwd PE 5.32
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -74.66%
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.35
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.03
Quick Ratio 0.03
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-16327.37%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y-217.94%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-19.87%
Revenue growth 3Y103.08%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y